Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
A speaker warns “Nick Shirley’s coming to town" while criticizing San Francisco leaders over fentanyl deaths, crime, and homelessness during a Board of Supervisors meeting....
Brooklyn daycare director allegedly stole $2.75M, spending on wrestling, luxury goods, and food delivery....
